JP Patent

JP6588600B2 — Ｎｈｅ３結合化合物およびリン酸輸送の阻害方法

Assigned to アーデリクス，インコーポレーテッド · Expires 2019-10-09 · 7y expired

What this patent protects

Patent listed against tenapanor-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP6588600B2
Jurisdiction
JP
Classification
—
Expires
2019-10-09
Drug substance claim
No
Drug product claim
No
Assignee
アーデリクス，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.